Omnichannel isn’t about more plays, it’s about the system
Omnichannel in pharma is no longer about adding more plays across channels—it’s about operating as a coordinated, real-time system that connects touchpoints rather than isolated tactics.
My partner, Josh Madej , EVP, Omnichannel Strategy + Digital Innovation, and I spend a lot of time talking about omnichannel, business, and where pharma is headed.
We also spend a surprising amount of time talking about football.
And the more we’ve watched how the game continues to evolve, the more it’s started to feel like a pretty good metaphor for where omnichannel is going in 2026.
Because omnichannel today is a lot like the Super Bowl.
Everyone sees the plays on the field; the passes, the runs, the touchdowns. That’s what channels look like from the outside: email, CRM, portals, reps, media. For a long time, success felt like calling the right play at the right time.
But the teams that actually win the Super Bowl aren’t just calling good plays. They’re running a system.
They have real-time visibility into what’s happening, coordination across every unit, and feedback loops that allow them to adjust mid-game, not after the season is over. Every play builds on the last. Nothing happens in isolation.
That’s the same shift now happening with omnichannel in pharma.
From Plays to an Operating Model
Historically, omnichannel was treated as a strategy layered on top of execution, more channels, more campaigns, more coordination.
In early 2026, that approach is no longer enough.
We’re seeing omnichannel evolve from a channel-led strategy into an operating model, and in some cases, an operating system, that underpins how organizations plan, execute, and learn.
Instead of being about launching new tactics, omnichannel is becoming the connector:
- Connecting commercial and medical efforts
- Connecting online and offline touchpoints
- Connecting data, content, technology, and analytics
- Connecting internal teams and external partners
The focus shifts from activity to continuity, both for teams and for HCPs.
Why This Shift Matters
This evolution is being driven by real-world pressure. HCP engagement is fragmented. Expectations are shaped by consumer experiences. Data sources are changing. Platforms and regulations evolve constantly.
Static omnichannel plans can’t keep up.
An operating-model approach allows organizations to activate across channels without increasing coordination overhead, adapt more quickly to change, and move from a “yes, but” mindset to a “yes, and” mindset, adding new channels, partners, and ideas without adding unnecessary complexity.
Omnichannel is the ultimate team sport.
One part of the Super Bowl metaphor that’s worth calling out explicitly and something I often emphasize is this:
No omnichannel program succeeds because of a single role, function, or discipline. It takes individual contributors across the organization to make the system work together, from analysts to strategists, scientists, creatives to technologists, and everything in between.
Each role brings a critical skillset. But the real impact comes from how those skills are orchestrated.
When omnichannel is treated as a collection of individual efforts, even strong execution can feel disjointed. Insights don’t travel. Decisions slow down. The experience fragments, internally first, and externally soon after.
An omnichannel operating model changes that dynamic. It creates shared visibility, shared language, and shared accountability, allowing specialists to stay specialists, while still contributing to a connected whole.
The Takeaway
Just like the Super Bowl isn’t won on a single play, omnichannel leadership in pharma won’t come from a single channel or campaign.
It will come from the strength of the system underneath it.
Because the more connected the work is internally, across people, teams, tools, and decisions, the more connected and meaningful the experience becomes externally for the end user.
This article was originally published on LinkedIn.